Dr. Brian Rotenberg, MD
Claim this profileSt. Joseph's Healthcare London
Studies Sinusitis
Studies Chronic Rhinosinusitis
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Brian Rotenberg, MD is currently running
Dupilumab
for Nasal Polyps
The study aims to investigate the olfactory TDI score (Threshold, Discrimination, Identification) using the Sniffin' sticks test for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) on dupilumab. Twenty-seven adult patients will be followed up during the treatment with dupilumab on three visits to the Otolaryngology Clinic (Baseline, 3 months and 6 months). The primary endpoint will be the TDI score. Nasal polyp score, Quality of Olfactory Disorders - negative symptoms (QOD-NS symptom scores), SNOT-22 will be secondary endpoints.
Recruiting4 awards Phase 44 criteria
Celecoxib
for Chronic Rhinosinusitis
This is a proposed randomized prospective study to evaluate both the anti-inflammatory and analgesic effects of a COX-2 inhibitor, celecoxib, in patients with aspirin-exacerbated respiratory disease and Chronic rhinosinusitis following endoscopic sinus surgery. The investigators hypothesize that supplementation with celecoxib can potentially improve surgical outcomes and reduce the postoperative usage of opioid analgesics without an increased risk of bleeding or asthma exacerbation
Recruiting2 awards Phase 43 criteria
More about Brian Rotenberg, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Brian Rotenberg, MD has experience with
- Celecoxib
- Placebo
- Dupilumab
Breakdown of trials Brian Rotenberg, MD has run
Chronic Rhinosinusitis
Respiratory Diseases
Respiratory Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian Rotenberg, MD specialize in?
Brian Rotenberg, MD focuses on Sinusitis and Chronic Rhinosinusitis. In particular, much of their work with Sinusitis has involved treating patients, or patients who are undergoing treatment.
Is Brian Rotenberg, MD currently recruiting for clinical trials?
Yes, Brian Rotenberg, MD is currently recruiting for 2 clinical trials in London Ontario. If you're interested in participating, you should apply.
Are there any treatments that Brian Rotenberg, MD has studied deeply?
Yes, Brian Rotenberg, MD has studied treatments such as Celecoxib, Placebo, Dupilumab.
What is the best way to schedule an appointment with Brian Rotenberg, MD?
Apply for one of the trials that Brian Rotenberg, MD is conducting.
What is the office address of Brian Rotenberg, MD?
The office of Brian Rotenberg, MD is located at: St. Joseph's Healthcare London, London, Ontario N6A 4V2 Canada. This is the address for their practice at the St. Joseph's Healthcare London.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.